{"id":626809,"title":"Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-28","captureTimestamp":"2026-02-28T01:11:05.298000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/policy-pharmacometrics-drug-submissions-clinical-trials-applications.html","snippet":"Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications Pharmacometric approaches play an increasing role in developing drug submissions and clinical trial applications (CTAs). Find out what sponsors should consider when preparing drug…","rawSnapshotUrl":"/api/snapshots/raw/626809","browseUrl":"https://replay.healtharchive.ca/job-6/20260228011105/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/policy-pharmacometrics-drug-submissions-clinical-trials-applications.html#ha_snapshot=626809","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}